课题基金 / 基金详情

COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-

COLLABORATION OF GROWTH FACTOR AND ONCOGENE PRODUCT IN HEPATOCARCINOGENESIS AND LIVER REGENERATION -ANALYSIS BY DOUBLE TRANSGENIC MICE-
生长因子和癌基因产物在肝癌发生和肝脏再生中的协同作用-双转基因小鼠分析-
批准号:
09670510
负责人:
TAKAGI Hitoshi
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

TAKAGI Hitoshi的其他基金

相似基金

相关文献

中文摘要
翻译
转化生长因子(Transforming growth factor,TGF)α和原癌基因ras通过激活酪氨酸激酶参与细胞内信号转导,我们和其他研究小组分别建立了TGF α转基因小鼠(T)和ras转基因小鼠(R),两种转基因小鼠均表现出特征性的表型,如肝细胞癌、胰腺纤维化(T)和脾肉瘤、皮肤乳头状瘤(R)。建立了TGF α和ras双转基因小鼠(T+R),并对其表型、肿瘤形成和肝再生进行了分析。首先,T+R组的体重和肝重比均低于T组和R组;出生后12个月,15例T + R中有4例出现大肝癌和腺瘤。15例(R)中4例发生皮肤乳头状瘤,15例(T)中2例发生肝腺瘤。增殖细胞核抗原(PCNA)在T+R组肝肿瘤中阳性率超过10%,在T+R组非肿瘤肝组织中阳性率约为1%,而在非肿瘤肝组织中阳性率低于1%。皮肤肿瘤和脾肉瘤在T + R组较R组无明显增强,胰腺重量在T + R组较T或兰德重,胰腺纤维化在T+R组较T或R组增强。TGF-α和ras也可促进胰腺纤维化,从而促进胰腺生长。
英文摘要
Transforming growth factor(TGF)alpha and protooncogene ras are involved inthe intracellular signal transduction through the activation of tyrosine kinase.We and other group have developed TGFalpha transgenic mice(T) and ras transgenicmice(R) independently, Both of the transgenic mice showed characteristicphenotypes e.g. hepatocellular carcinoma, pancreatic fibrosis for (T) andsplenic sarcoma and skin papilloma for (R). We made the double transgenic miceof TGFalpha and ras(T+R) and analyzed the phenotype, tumor formation, and liverregeneration. First of all, T+R had lower body weight than T and R and the rate ofliver weight! body weight was significantly higher in T+R than single T or R.Large hepato cellular carcinoma and adenoma were observed in 4 of 15 T+R 12months after birth. Four of 15(R) developed skin papilloma and 2 of 15 (T) didhepatic adenoma. More than 10% of hepatocytes were positively stained byproliferating cell nuclear antigen(PCNA) in liver tumors of T+R and about 1% ofnon-tumor tissue of T+R.On the other hand, non-tumor liver showed less than1% by PCNA.Compared with T and R, T+R showed enhanced regeneration of theliver after 2/3 hepatectomy. Skin tumor and splenic sarcoma was not enhancedin T+R compared with R.he weight of pancreas was heavier in T+R than T or Rand pancreatic fibrosis was enhanced in T+R than T or R.Thus simultaneous overexpression of TGFa and ras inhibited the growth ofthe mice and enhanced the growth of the liver, hepatic tumor formation andregeneration. Pancreatic fibrosis was also enhanced by TGFalpha and ras, resultingin enhanced growth of pancreas.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Takayama H,et al: "Analysis of the hepatic and gastrointestinal phenotype of HGF/SF transgenic mice.(in Japanese)" Frontiers in Gastroenterology. 2. 252-260 (1997)
Takayama H 等人:“HGF/SF 转基因小鼠的肝脏和胃肠道表型分析。(日语)”胃肠病学前沿。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Takagi H, et al: "Steroid hormone-dependent overexpression of cytochrome p450 2A in liver tumor of TGFα transgenic mice." J Gastroenterol. 32. 708-711 (1997)
Takagi H 等人:“TGFα 转基因小鼠肝脏肿瘤中细胞色素 p450 2A 的类固醇激素依赖性过度表达。” J Gastroenterol。 32. 708-711 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 30 条
    Development of low-cost extraction method for cellulose nanofiber from paper sludge and application to biocomposites
    • 批准号:
      24656394
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2012
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Clinical evidence-based investigation of developmental mechanism in diabetic retinopathy
    • 批准号:
      23592594
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Development of nano cellulose fiber green composites fabricated by combining controlled solidification and freeze-drying
    • 批准号:
      20560642
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    Combination therapy of apoptosis induction and molecular targeting for hepatocellular carcinoma. -Transgenic mice study-
    • 批准号:
      15590619
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      2003
    • 负责人:
      TAKAGI Hitoshi
    • 依托单位:
    国内基金
    海外基金
    金荞麦黄酮靶向抑制c-MET介导的PI3K/Akt和Ras/MAPK通路逆转NSCLC EGFR-TKI耐药的机制研究
    • 批准号:
      2026JJ81256
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李弘德
    • 依托单位:
    槲皮素基于P53/Ras调控细胞凋亡增殖抗OSF癌变的机制研究
    • 批准号:
      2026JJ82512
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      王韧
    • 依托单位:
    lncRNA H19通过介导Ras/ULK1信号影响乳腺癌细胞线粒体稳态及糖酵解的作用及机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      施文标
    • 依托单位:
    组织驻留菌Eggerthella lenta 通过代 谢重编程Ras通路介导的细胞凋亡抑制结 直肠癌的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2025
    • 负责人:
      陈一纬
    • 依托单位: